As several other posters have noted, AM-101 appears to be shaping up to be an underwhelming treatment. I can envision a downside to AM-101's entrance into the marketplace. Let's assume AM-101 passes all of the necessary regulatory, investor, and internal hurdles. When a distressed patient...